Trial intelligence / Profile preview

Genomic of CONgenital Sideroblastic Anemias

NCT07459816Recruiting

Sponsor
CHU Amiens-Picardie
Start
Oct 2025
Primary completion
Nov 2026
Countries
1
01

Overview

Trial (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoints: Identification of genetic variants in Congenital sideroblastic anemias at 1 year and Identification of nonsense and missense genetic variants in Congenital sideroblastic anemias at 1 year. Started Oct 2025; status: recruiting.

Beyond the preview

Go deeper on NCT07459816.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07459816.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call